Skip to main content

Table 1 Comparison of baseline information between the healthy control group and ACS group

From: Downregulation of serum miR-30c-5p serves as a biomarker to predict disease onset and short-term prognosis in acute coronary syndrome patients

Indicators

HC group (n = 65)

ACS group (n = 98)

P-value

Age (years)

56.65 ± 7.43

57.56 ± 10.45

0.542

Gender (male)

41 (63.08%)

59 (60.20%)

0.712

BMI (kg/m2)

22.23 ± 1.93

22.64 ± 2.24

0.228

T2DM

20 (30.77%)

21 (21.43%)

0.178

HBP

7 (10.77%)

21 (21.43%)

0.077

HLP

10 (15.38%)

26 (26.53%)

0.093

Drink

28 (43.08%)

36 (36.73%)

0.417

Smoke

22 (33.85%)

47 (47.96%)

0.074

WBC (1*109/L)

7.03 ± 1.34

7.82 ± 1.74

0.002*

PLT (1*109/L)

202.99 ± 17.51

211.13 ± 21.39

0.012*

CK-MB (U/L)

15.67 ± 3.03

18.98 ± 6.70

0.0003*

TC (mmol/L)

4.29 ± 0.62

4.52 ± 0.93

0.092

TG (mmol/L)

1.52 ± 0.27

1.66 ± 0.50

0.033*

HDL-C (mmol/L)

1.10 ± 0.22

1.05 ± 0.10

0.044*

LDL-C (mmol/L)

2.82 ± 0.31

3.02 ± 0.58

0.012*

FBG (mmol/L)

5.20 ± 0.82

5.33 ± 0.41

0.182

cTnI (µg/L)

-

1.48 ± 1.15

-

hs-CRP (mg/L)

-

6.49 ± 0.79

-

GS

-

50.65 ± 15.30

-

  1. Note *P<0.05. BMI: body mass index; T2DM: type II diabetes mellitus; HBP: hypertension; HLP: hyperlipidemia; WBC: white blood cells; PLT: platelet; CK-MB: creatine kinase isoenzymes - MB; TC: total cholesterol; TG: triglyceride; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; FBG: fasting blood glucose; cTnI: cardiac troponin I; hs-CRP: hypersensitive C-reactive protein; NT-proBNP: N-terminal B-type natriuretic peptide precursor; GS: Gensini score